Related Experiment Videos
[Cytomegalovirus and the fetus]
M Van Lierde1, V Gaudy, B Mulongo
1Service Obstétrique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgique.
Pathologie-Biologie
|September 1, 1992
Summary
Maternal cytomegalovirus (CMV) infection poses risks to fetuses and newborns. Early screening, diagnosis, and new treatments are crucial for prevention and management.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Neonatology
Context:
- Cytomegalovirus (CMV) infection in pregnant individuals can be primary or reactivated.
- Congenital CMV infection poses significant risks to fetal and neonatal health.
- Existing literature on maternal CMV infection risks is reviewed.
Purpose:
- To review the literature on fetal and neonatal risks associated with maternal CMV infection.
- To discuss reported risk rates and mechanisms of fetal CMV transmission.
- To advocate for improved screening, diagnosis, and therapeutic strategies.
Summary:
- Maternal cytomegalovirus (CMV) infection, including primary and reactivated cases, presents substantial risks to the fetus and neonate.
- The review details varying risk rates and elucidates the mechanisms by which the fetus becomes infected.
- The study emphasizes the need for enhanced screening protocols for maternal CMV infection and antenatal diagnostic methods for fetal infection.
Impact:
- Highlights the importance of early detection and intervention for congenital CMV.
- Advocates for the development of novel antiviral therapies and preventative immunizations.
- Aims to reduce the incidence and severity of congenital CMV disease through improved clinical practices.